Pfizer and BioNTech plan to seek Food and Drug Administration emergency use authorization for their COVID-19 vaccine in kids ages 5 to 11.Pfizer and BioNTech plan to seek Food and Drug Administration emergency use authorization for their COVID-19 vaccine in kids ages 5 to 11.Read More
